Europa · Agencias y tiempo real · Reuters Technology

Danaher says it has 'building blocks' for AI drug discovery growth

Publicado por Reuters Technology · Reino Unido hace 11 h

Life sciences firm Danaher is well positioned to ‌benefit as drugmakers increasingly adopt artificial intelligence to develop new medicines, its chief executive said on Wednesday,…

Leer el artículo completo en Reuters Technology Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.reuters.com)

Danaher says it has 'building blocks' for AI drug discovery growth

También te puede interesar

Russia-US communication channel could help spread truth about Alyoshki — diplomat

Türkiye's BIST 100 index down at midweek close

As Russia penalises European firms over Ukraine, US rivals largely spared

As Russia penalises European firms over Ukraine, US rivals largely spared

Correction to copper grade A cathode low-carbon combined premium, fca Europe

Kalshi could be headed for Supreme Court showdown, CEO says

Danaher says it has 'building blocks' for AI drug discovery growth

Compartir

También te puede interesar

Russia-US communication channel could help spread truth about Alyoshki — diplomat

Türkiye's BIST 100 index down at midweek close

As Russia penalises European firms over Ukraine, US rivals largely spared

As Russia penalises European firms over Ukraine, US rivals largely spared

Correction to copper grade A cathode low-carbon combined premium, fca Europe

Kalshi could be headed for Supreme Court showdown, CEO says